major depressive disorder

brain amyloid alzheimers strings detailed web complicated thought

Abbott begins neuromodulation trial in drug-resistant depression

The FDA previously granted Abbott a breakthrough designation for aiming the technology toward the areas of the brain that regulate mood.

Conor Hale Sep 4, 2024 11:02am

sleep insomnia clock depression sad

J&J's oral add-on aces phase 3 in major depressive disorder

May 29, 2024 11:55am

pills prescription

Neurocrine-Takeda antidepressant hits main mark in phase 2 trial

Apr 23, 2024 10:44am

Front view of unrecognizable mature woman sitting at the table and typing a text message on her smart phone

FDA clears Otsuka, Click's prescription app for depression

Apr 3, 2024 1:53pm

brain neurostimulation

Neuronetics TMS nets first-line OK for depression in adolescents

Mar 26, 2024 11:02am

IPO

Alto Neuroscience preps IPO to push CNS therapies through clinic

Jan 16, 2024 6:51am